Getting into the Game | GenomeWeb

Getting into the Game

As our sister publications Pharmacogenomics Reporter and In Sequence report, Illumina has gotten into the personal genome-sequencing game. For $48,000 Illumina will sequence someone's genome, using its Genome Analyzer II, and provided that person has a prescription.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.